TransMedics (TMDX Quick QuoteTMDX - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TMDX broke through the 200-day moving average, which suggests a long-term bullish trend.

A useful tool for traders and analysts, the 200-day simple moving average helps determine long-term market trends for stocks, commodities, indexes, and other financial instruments. It moves higher or lower in conjunction with longer-term price performance, and serves as a support or resistance level.

TMDX has rallied 20% over the past four weeks, and the company is a Zacks Rank #3 (Hold) at the moment. This combination suggests TMDX could be on the verge of another move higher.

The bullish case solidifies once investors consider TMDX's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 3 higher, while the consensus estimate has increased too.

Given this move in earnings estimate revisions and the positive technical factor, investors may want to keep their eye on TMDX for more gains in the near future.